T cells failed to clear MHC-I null cancer cells upon NKG2D-blockade and, in the absence of blockade, T cells only eliminated CT2A-TRP2-βmKO cells in the presence of OVA-expressing APCs in a Fas/FasL-dependent manner (93). This evidence concerns the gene KLRK1 and cancer.